Warning: The NCBI web site requires JavaScript to function. more...
CD44+/CD24- breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis.
Sheridan C, Kishimoto H, Fuchs RK, Mehrotra S, Bhat-Nakshatri P, Turner CH, Goulet R Jr, Badve S, Nakshatri H.
Breast Cancer Res. 2006;8(5):R59.
Related citations
Role of CCL5 in invasion, proliferation and proportion of CD44+/CD24- phenotype of MCF-7 cells and correlation of CCL5 and CCR5 expression with breast cancer progression.
Zhang Y, Yao F, Yao X, Yi C, Tan C, Wei L, Sun S.
Oncol Rep. 2009 Apr;21(4):1113-21.
A novel mouse model of human breast cancer stem-like cells with high CD44+CD24-/lower phenotype metastasis to human bone.
Ling LJ, Wang S, Liu XA, Shen EC, Ding Q, Lu C, Xu J, Cao QH, Zhu HQ, Wang F.
Chin Med J (Engl). 2008 Oct 20;121(20):1980-6.
Tumor-endothelial interaction links the CD44(+)/CD24(-) phenotype with poor prognosis in early-stage breast cancer.
Buess M, Rajski M, Vogel-Durrer BM, Herrmann R, Rochlitz C.
Neoplasia. 2009 Oct;11(10):987-1002.
[Detection of breast cancer stem cells and the expression of key molecules in Hedgehog signaling pathway].
Lu ZH, Jia J, Ren J, Ma B, DI LJ, Song GH.
Beijing Da Xue Xue Bao. 2008 Oct 18;40(5):480-5. Chinese.
The CD44+/CD24- phenotype is enriched in basal-like breast tumors.
Honeth G, Bendahl PO, Ringnér M, Saal LH, Gruvberger-Saal SK, Lövgren K, Grabau D, Fernö M, Borg A, Hegardt C.
Breast Cancer Res. 2008;10(3):R53. Epub 2008 Jun 17.
Twist modulates breast cancer stem cells by transcriptional regulation of CD24 expression.
Vesuna F, Lisok A, Kimble B, Raman V.
Neoplasia. 2009 Dec;11(12):1318-28.
Brca1 breast tumors contain distinct CD44+/CD24- and CD133+ cells with cancer stem cell characteristics.
Wright MH, Calcagno AM, Salcido CD, Carlson MD, Ambudkar SV, Varticovski L.
Breast Cancer Res. 2008;10(1):R10. Epub 2008 Feb 1.
Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy.
Fillmore CM, Kuperwasser C.
Breast Cancer Res. 2008;10(2):R25. Epub 2008 Mar 26.
Breast cancer stem cells and intrinsic subtypes: controversies rage on.
Nakshatri H, Srour EF, Badve S.
Curr Stem Cell Res Ther. 2009 Jan;4(1):50-60. Review.
Dynamic regulation of CD24 and the invasive, CD44posCD24neg phenotype in breast cancer cell lines.
Meyer MJ, Fleming JM, Ali MA, Pesesky MW, Ginsburg E, Vonderhaar BK.
Breast Cancer Res. 2009;11(6):R82. Epub 2009 Nov 11.
CD44(+)/CD24(-) cells are transit progenitors and do not determine the molecular subtypes and clinical parameters in breast carcinomas.
Lü X, Xu K, Lü H, Yin Y, Ma C, Liu Y, Li H, Suo Z.
Ultrastruct Pathol. 2011 Apr;35(2):72-8.
High aldehyde dehydrogenase and expression of cancer stem cell markers selects for breast cancer cells with enhanced malignant and metastatic ability.
Croker AK, Goodale D, Chu J, Postenka C, Hedley BD, Hess DA, Allan AL.
J Cell Mol Med. 2009 Aug;13(8B):2236-52. Epub 2008 Aug 4.
Characterisation of breast cancer cell lines and establishment of a novel isogenic subclone to study migration, invasion and tumourigenicity.
Hughes L, Malone C, Chumsri S, Burger AM, McDonnell S.
Clin Exp Metastasis. 2008;25(5):549-57. Epub 2008 Apr 2.
Prolonged drug selection of breast cancer cells and enrichment of cancer stem cell characteristics.
Calcagno AM, Salcido CD, Gillet JP, Wu CP, Fostel JM, Mumau MD, Gottesman MM, Varticovski L, Ambudkar SV.
J Natl Cancer Inst. 2010 Nov 3;102(21):1637-52. Epub 2010 Oct 8.
[Analysis on clone in vitro and tumorigenic capacity in vivo of different subsets cells from the MCF-7 human breast cancer cell line].
Li Z, Liu CP, He YL, Tian Y, Huang T.
Sichuan Da Xue Xue Bao Yi Xue Ban. 2008 Jul;39(4):547-9. Chinese.
Multiple lineages of human breast cancer stem/progenitor cells identified by profiling with stem cell markers.
Hwang-Verslues WW, Kuo WH, Chang PH, Pan CC, Wang HH, Tsai ST, Jeng YM, Shew JY, Kung JT, Chen CH, Lee EY, Chang KJ, Lee WH.
PLoS One. 2009 Dec 21;4(12):e8377.
Identification of the functional role of peroxiredoxin 6 in the progression of breast cancer.
Chang XZ, Li DQ, Hou YF, Wu J, Lu JS, Di GH, Jin W, Ou ZL, Shen ZZ, Shao ZM.
Breast Cancer Res. 2007;9(6):R76.
Breast cancer stromal fibroblasts promote the generation of CD44+CD24- cells through SDF-1/CXCR4 interaction.
Huang M, Li Y, Zhang H, Nan F.
J Exp Clin Cancer Res. 2010 Jun 22;29:80.
Breast cancer stem cell markers CD44, CD24 and ALDH1: expression distribution within intrinsic molecular subtype.
Ricardo S, Vieira AF, Gerhard R, Leitão D, Pinto R, Cameselle-Teijeiro JF, Milanezi F, Schmitt F, Paredes J.
J Clin Pathol. 2011 Nov;64(11):937-46. Epub 2011 Jun 16.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on